Randomized clinical trial comparing fixed-time split dosing and split dosing of oral Picosulfate regimen for bowel preparation

A Blinded Clinical Trial comparing the Efficacy and Tolerability of Picolight(fixed split dose regimen) for colonoscopy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0002348

Enrollment

240

Registered

2017-06-09

Start date

2014-08-28

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Each group received three sachets of sodium picosulfate (Picolight® powder, Pharmbio Korea Co., Ltd, Seoul, Korea), each containing sodium picosulfate hydrate 10 mg, magnesium oxide 3.5 g, and

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Health screening, Family history of Colon cancer, Irritable bowel syndrome, follow up for Colon polyp

Exclusion criteria

Exclusion criteria: 1) pregnant women; 2) acute abdomen; 3) history of dehydration and /or drug allergy; 4) congestive heart failure; 5) chronic liver disease or renal insufficiency; 6) history of colon resection or abdominal surgery within six months; 7) participation in other clinical studies within four weeks prior to randomization.

Design outcomes

Primary

Measure	Time frame
effect of bowel clearance	—

Secondary

Measure	Time frame
patient's compliance	—

Countries

Korea, Republic of

Contacts

Public ContactKoonhee Han

GangNeung Asan Hospital

hankoonhee@hanmail.net+82-33-610-3133

Outcome results